Home/Filings/4/0001437749-16-034509
4//SEC Filing

Sun BioPharma, Inc. 4

Accession 0001437749-16-034509

CIK 0001029125operating

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 12:30 PM ET

Size

6.6 KB

Accession

0001437749-16-034509

Insider Transaction Report

Form 4
Period: 2016-06-24
KAYSEN DAVID B
President and CEO
Transactions
  • Purchase

    Warrant (right to buy)

    2016-06-24+25,00025,000 total
    Exercise: $1.50From: 2016-06-24Exp: 2021-06-24Common Stock (25,000 underlying)
  • Purchase

    Common Stock

    2016-06-24+50,00050,000 total
Footnotes (1)
  • [F1]Reported securities purchased as one share of common stock and one warrant to purchase one-half share of common stock for a combined price of $1.00 per "unit."

Issuer

Sun BioPharma, Inc.

CIK 0001029125

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001029125

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 12:30 PM ET
Size
6.6 KB